-
Product Insights
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2017" provides an overview of Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by...
-
Product Insights
House Dust Mite Allergy Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “House Dust Mite Allergy Global Clinical Trials Review, H2, 2017" provides an overview of House Dust Mite Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on House Dust Mite Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Sector Analysis
KOL Perspectives: Dose Tapering Strategies in Rheumatoid Arthritis
› This KOL Insight briefing focuses on dose tapering strategies in patients receiving targeted therapy for rheumatoid arthritis (RA)
-
Product Insights
Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Global Clinical Trials Review, H2, 2017" provides an overview of Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Mucocutaneous Lymph Node Syndrome (Kawasaki Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Kidney Transplant Rejection Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Kidney Transplant Rejection Global Clinical Trials Review, H2, 2017" provides an overview of Kidney Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical trials on Kidney Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Lambert–Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Lambert–Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2017" provides an overview of Lambert–Eaton Myasthenic Syndrome (LEMS) clinical trials scenario. This report provides top line data relating to the clinical trials on Lambert–Eaton Myasthenic Syndrome (LEMS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Milk Allergy Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Milk Allergy Global Clinical Trials Review, H2, 2017" provides an overview of Milk Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Milk Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Allergies Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Allergies Global Clinical Trials Review, H1, 2017" provides an overview of Allergies clinical trials scenario. This report provides top line data relating to the clinical trials on Allergies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H1, 2017" provides an overview of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Angioedema Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Angioedema Global Clinical Trials Review, H1, 2017" provides an overview of Angioedema clinical trials scenario. This report provides top line data relating to the clinical trials on Angioedema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.